Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional Information (Details)

v3.22.1
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 12 Months Ended
Oct. 22, 2019
$ / shares
shares
Mar. 31, 2022
USD ($)
segment
shares
Mar. 31, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Financing Receivable, Impaired [Line Items]        
Tangible asset impairment charges | $   $ 0 $ 0  
Asset impairment charges | $   0 0  
Goodwill impairment loss | $   $ 0   $ 0
Recapitalization conversion ratio   0.8293    
Common stock, shares issued (in shares) 1 48,845,706   48,627,739
Research and development expense | $   $ 2,065,000 1,310,000  
Advertising expense | $   $ 558,000 144,000  
Percentage of largest benefit greater than likelyhood of resolution for tax benefit measurement   50.00%    
Deferred tax assets | $   $ 0 $ 0  
Effective income tax reconciliation rate   0.00% 0.00%  
Weighted average shares included in computation of earning per share (in shares)   4,339,216 3,819,748  
Number of operating segments | segment   1    
Minimum        
Financing Receivable, Impaired [Line Items]        
Intangible asset useful life   3 years    
Lease terms   5 years    
Maximum        
Financing Receivable, Impaired [Line Items]        
Intangible asset useful life   8 years    
Lease terms   10 years    
IPO        
Financing Receivable, Impaired [Line Items]        
Stock issued during period new shares issued (in shares) 13,800,000      
Shares issued (in shares) 1      
Purchase price per share (in USD per share) | $ / shares $ 10.00      
Exercise price of warrants or rights (dollars per share) | $ / shares $ 11.50      
IPO | Private Warrants        
Financing Receivable, Impaired [Line Items]        
Warrants issued (in shares) 1      
Private Placement | Private Warrants        
Financing Receivable, Impaired [Line Items]        
Stock issued during period new shares issued (in shares) 4,110,000      
Exercise price of warrants or rights (dollars per share) | $ / shares $ 1.00      
Conversion of promissory note, warrants issued 500,000